These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1847867)

  • 1. Efficient renaturation and fibrinolytic properties of prourokinase and a deletion mutant expressed in Escherichia coli as inclusion bodies.
    Orsini G; Brandazza A; Sarmientos P; Molinari A; Lansen J; Cauet G
    Eur J Biochem; 1991 Feb; 195(3):691-7. PubMed ID: 1847867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
    Holvoet P; Laroche Y; Lijnen HR; Van Hoef B; Brouwers E; De Cock F; Lauwereys M; Gansemans Y; Collen D
    Eur J Biochem; 1992 Dec; 210(3):945-52. PubMed ID: 1483477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
    Lijnen HR; Stump DC; Collen DC
    Semin Thromb Hemost; 1987 Apr; 13(2):152-9. PubMed ID: 3114883
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of a recombinant chimeric plasminogen activator consisting of a fibrin peptide and a low molecular mass single-chain urokinase.
    Jiao J; Yu M; Ru B
    Biochimie; 2001; 83(11-12):1049-55. PubMed ID: 11879733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase mutant with better fibrin-specificity.
    Ma Z; Yu R; Hua Z; Zhu D
    Sci China C Life Sci; 1996 Oct; 39(5):523-33. PubMed ID: 9772355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala.
    Lijnen HR; Li XK; Nelles L; Hu MH; Collen D
    Eur J Biochem; 1992 Apr; 205(2):701-9. PubMed ID: 1533368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
    Gurewich V; Pannell R; Broeze RJ; Mao J
    J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of deletion mutants of the Escherichia coli UvrA protein and their purification from inclusion bodies.
    Claassen LA; Ahn B; Koo HS; Grossman L
    J Biol Chem; 1991 Jun; 266(17):11380-7. PubMed ID: 1645734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis with prourokinase versus urokinase: an in vitro comparison.
    Fox D; Ouriel K; Green RM; Stoughton J; Riggs P; Cimino C
    J Vasc Surg; 1996 Apr; 23(4):657-66. PubMed ID: 8627903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient system for production of recombinant urokinase-type plasminogen activator.
    Tang W; Sun ZY; Pannell R; Gurewich V; Liu JN
    Protein Expr Purif; 1997 Dec; 11(3):279-83. PubMed ID: 9425632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
    Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
    Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro refolding of cyclomaltodextrin glucanotransferase from cytoplasmic inclusion bodies formed upon expression in Escherichia coli.
    Hellman J; Lassila P; Mäntsälä P
    Protein Expr Purif; 1995 Feb; 6(1):56-62. PubMed ID: 7756839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.
    Cajot JF; Schleuning WD; Medcalf RL; Bamat J; Testuz J; Liebermann L; Sordat B
    J Cell Biol; 1989 Aug; 109(2):915-25. PubMed ID: 2503527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies.
    Lee HJ; Im H
    Protein Expr Purif; 2003 Sep; 31(1):99-107. PubMed ID: 12963346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prourokinase-annexin V chimeras. Construction, expression, and characterization of recombinant proteins.
    Tait JF; Engelhardt S; Smith C; Fujikawa K
    J Biol Chem; 1995 Sep; 270(37):21594-9. PubMed ID: 7665573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.